Showing results (571-580 of 664) with videos related to
Sort By:
Pageof 67
International Journal of Pediatric Otorhinolaryngology|December 28, 2019
Panel 4: Recent advances in understanding the natural history of the otitis media microbiome and its response to environmental pressuresRobyn L Marsh, Celestine Aho, Jemima Beissbarth, et al.Hemasphere|June 9, 2026
Obinutuzumab, lenalidomide, and venetoclax for the initial treatment of patients with advanced-stage follicular lymphoma: Results of the Phase Ib/II LEVERAGE studyChan Y Cheah, Piers Blombery, Amanda Johnston, et al.Anaesthesia|February 19, 2016
Association of Anaesthetists of Great Britain and Ireland: Safe vascular access 2016A Bodenham Chair, S Babu, J Bennett, et al.Ecology|May 30, 2023
Historical pesticide applications for the treatment of eastern spruce budworm infestations in New BrunswickShane Heartz, David A MacLean, Rob C Johns, et al.BMC Ear, Nose, and Throat Disorders|October 9, 2013
Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforationHeidi C Smith-Vaughan, Michael J Binks, Robyn L Marsh, et al.Open Forum Infectious Diseases|September 1, 2020
Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort StudyJane Davies, Emma L Smith, Margaret Littlejohn, et al.Clinical Pharmacology and Therapeutics|June 17, 2022
Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID-19, in Subjects With Renal ImpairmentSima S Toussi, Joel Michael Neutel, Jesus Navarro, et al.Science Advances|October 13, 2016
Combinatorial microfluidic droplet engineering for biomimetic material synthesisLukmaan A Bawazer, Ciara S McNally, Christopher J Empson, et al.BMC Pregnancy and Childbirth|May 7, 2023
Inequity of antenatal influenza and pertussis vaccine coverage in Australia: the Links2HealthierBubs record linkage cohort study, 2012-2017Lisa McHugh, Annette K Regan, Mohinder Sarna, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 30, 2025
Cardiac safety of fordadistrogene movaparvovec gene therapy in Duchenne muscular dystrophy: Initial observations from a phase 1b trialSarah P Sherlock, Daniel I Levy, Avery McIntosh, et al.Pageof 67